Encare Spermicide Safety During Pregnancy: What You Need to Know
Encare (nonoxynol-9 vaginal suppository) is a spermicidal contraceptive. Its safety profile in established pregnancy is reassuring but comes with caveats.
Key Facts
- Active ingredient: Nonoxynol-9 (N-9), a surfactant that disrupts sperm membranes
- Pregnancy category: Not formally assigned (pre-1979); no teratogenicity in animal studies at clinical doses
- Systemic absorption: Minimal (<3% vaginal absorption); negligible fetal exposure
- Teratogenicity: No human or animal evidence of structural anomalies
- Miscarriage risk: No epidemiological association
Risks and Considerations
- Genital irritation: N-9 damages vaginal epithelium → increased HIV/STI susceptibility if exposed
- Contraceptive failure: Typical use failure rate ~21%; if pregnancy occurs, discontinue use
- Not for established pregnancy: No contraceptive indication once pregnant
- Microbiome disruption: May reduce lactobacilli → increased bacterial vaginosis/yeast risk
If You Used Encare Around Conception
- No evidence of harm to embryo or fetus
- Discontinue once pregnancy is confirmed
- No need for extra testing or termination
- Inform your OB for complete medication history
Better Contraception for the Future
- IUD (hormonal or copper) — >99% effective
- Implant — >99% effective
- Combined hormonal (pill, patch, ring) — 91% typical use
- Condoms + spermicide — 82% typical use (better than spermicide alone)
Always discuss contraceptive choices with your provider, especially if planning pregnancy.
Infertility - Related Articles
- Human-Animal Reproduction: Why Pregnancy Is Biologically Impossible
- Estimating Conception Date: How Doctors Calculate It
- Pregnancy Risk With Withdrawal Method on Ovulation Day: High
- Understanding the Causes of Reproductive Health Issues
- Ovulation Detection: Methods and Signs to Identify Peak Fertility
- Amniotic Band Syndrome: Treatment Options and Outcomes
- Puberty: Understanding the Maturation of Reproductive Organs
